Valuation: Pfizer

Market Cap 158B 141B 131B 120B 226B 15,232B 228B 1,590B 616B 7,787B 595B 582B 24,991B P/E 2026 *
17.5x
P/E 2027 * 13.6x
Enterprise Value 206B 183B 171B 156B 294B 19,797B 296B 2,067B 801B 10,121B 773B 756B 32,480B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 3.33x
Free-Float
59.05%
Yield 2026 *
6.19%
Yield 2027 * 6.24%
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 55 16/08/2026
Compliance Officer 65 01/12/2013
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 158B
-0.61%-3.43%+36.07%+115.04% 1,019B
-1.02%-5.60%+35.72%+64.63% 617B
+1.11%-0.58%+12.36%+77.95% 464B
+0.34%-3.01%+61.79%+41.24% 356B
-0.95%-4.05%+20.54%+41.71% 333B
-1.46%-2.89%+10.57%+32.81% 267B
-1.35%-5.43%-6.17%+8.98% 244B
-1.04%-2.79%+35.30%+51.84% 218B
-1.87%-4.10%+28.44%+93.66% 179B
Average -4.14%-3.54%+26.07%+58.65% 410.8B
Weighted average by Cap. -1.99%-3.54%+29.07%+70.57%

Financials

2026 *2027 *
Net sales 62.24B 55.3B 51.61B 47.04B 88.72B 5,983B 89.54B 625B 242B 3,059B 234B 229B 9,816B 59.88B 53.2B 49.66B 45.26B 85.36B 5,756B 86.15B 601B 233B 2,943B 225B 220B 9,444B
Net income 8.9B 7.91B 7.38B 6.73B 12.69B 856B 12.81B 89.32B 34.61B 437B 33.42B 32.69B 1,404B 11.08B 9.84B 9.19B 8.37B 15.8B 1,065B 15.94B 111B 43.09B 545B 41.6B 40.7B 1,748B
Net Debt 47.48B 42.19B 39.38B 35.89B 67.69B 4,565B 68.32B 477B 185B 2,334B 178B 174B 7,489B 40.98B 36.41B 33.98B 30.97B 58.42B 3,940B 58.96B 411B 159B 2,014B 154B 151B 6,463B
Logo Pfizer
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
27.80USD
Average target price
28.91USD
Spread / Average Target
+4.01%

Quarterly revenue - Rate of surprise